By MATTHEW PERRONE

WASHINGTON (AP) — Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and toddlers from RSV , the respiratory virus that sends thousands of American children to the hospital each year.

Related Articles

Mexican president says Mexico will send more water to US but not immediately

Trump threatens funding for Chicago transit after woman set on fire

Congressional lawmakers hear from Navy admiral overseeing boat strikes

What to know about the massive defense bill that seeks release of boat strike videos and more

About 400 immigrant children were detained longer than the recommended limit, ICE admits

The long-acting drugs from Merck and Sanofi are not vaccines, but the government review comes as health of

See Full Page